Cargando…

Association of RYR2 Mutation With Tumor Mutation Burden, Prognosis, and Antitumor Immunity in Patients With Esophageal Adenocarcinoma

Background: Esophageal adenocarcinoma (EAC) remains a leading cause of cancer-related deaths worldwide and demonstrates a predominant rising incidence in Western countries. Recently, immunotherapy has dramatically changed the landscape of treatment for many advanced cancers, with the benefit in EAC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zaoqu, Liu, Long, Jiao, Dechao, Guo, Chunguang, Wang, Libo, Li, Zhaonan, Sun, Zhenqiang, Zhao, Yanan, Han, Xinwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166246/ https://www.ncbi.nlm.nih.gov/pubmed/34079583 http://dx.doi.org/10.3389/fgene.2021.669694

Ejemplares similares

TTN/OBSCN ‘Double‐Hit’ predicts favourable prognosis, ‘immune‐hot’ subtype and potentially better immunotherapeutic efficacy in colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

Establishment and experimental validation of an immune miRNA signature for assessing prognosis and immune landscape of patients with colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

TP53 /KRAS Co-Mutations Create Divergent Prognosis Signatures in Intrahepatic Cholangiocarcinoma
por: Guo, Chunguang, et al.
Publicado: (2022)

USH2A Mutation is Associated With Tumor Mutation Burden and Antitumor Immunity in Patients With Colon Adenocarcinoma
por: Sun, Yuanyuan, et al.
Publicado: (2021)

A Comparative Study of Self-Expandable Metallic Stent Combined with Double (125)I Seeds Strands or Single (125)I Seeds Strand in the Treatment of Advanced Perihilar Cholangiocarcinoma with Malignant Obstructive Jaundice
por: Li, Zhaonan, et al.
Publicado: (2021)

Hypoxia Molecular Characterization in Hepatocellular Carcinoma Identifies One Risk Signature and Two Nomograms for Clinical Management
por: Liu, Zaoqu, et al.
Publicado: (2021)

Somatic mutations in homologous recombination pathway predict favourable prognosis after immunotherapy across multiple cancer types
por: Liu, Zaoqu, et al.
Publicado: (2021)

Novel miRNA Predicts Survival and Prognosis of Cholangiocarcinoma Based on RNA-seq Data and In Vitro Experiments
por: Yao, Yuan, et al.
Publicado: (2020)

Clinical Significance and Inflammatory Landscape of aNovel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

MR-guided microwave ablation of hepatocellular carcinoma (HCC): is general anesthesia more effective than local anesthesia?
por: Li, Zhaonan, et al.
Publicado: (2021)

Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma
por: Zhou, Xueliang, et al.
Publicado: (2021)

2450-MHz microwave ablation of liver metastases under 3.0 T wide-bore magnetic resonance guidance: a pilot study
por: Xu, Kaihao, et al.
Publicado: (2022)

MDN1 Mutation Is Associated With High Tumor Mutation Burden and Unfavorable Prognosis in Breast Cancer
por: Hao, Shuai, et al.
Publicado: (2022)

Comprehensive Molecular Analyses of a Novel Mutational Signature Classification System with Regard to Prognosis, Genomic Alterations, and Immune Landscape in Glioma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Microwave Ablation of Small Hepatic Metastases Using MR Guidance and Monitoring: Clinical Safety and Efficacy
por: Li, Zhaonan, et al.
Publicado: (2021)

Roles of Bile-Derived Exosomes in Hepatobiliary Disease
por: Yao, Yuan, et al.
Publicado: (2021)

CELF2 is a candidate prognostic and immunotherapy biomarker in triple‐negative breast cancer and lung squamous cell carcinoma: A pan‐cancer analysis
por: Wang, Libo, et al.
Publicado: (2021)

Mutations in lysine methyltransferase 2C and PEG3 are associated with tumor mutation burden, prognosis, and antitumor immunity in pancreatic adenocarcinoma patients
por: Huang, Yili, et al.
Publicado: (2022)

Glycolysis Changes the Microenvironment and Therapeutic Response Under the Driver of Gene Mutation in Esophageal Adenocarcinoma
por: Zhu, Lei, et al.
Publicado: (2021)

Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment
por: Xu, Hui, et al.
Publicado: (2022)

FAT3 Mutation Is Associated With Tumor Mutation Burden and Poor Prognosis in Esophageal Cancer
por: Guo, Zixin, et al.
Publicado: (2021)

Significance of Tumor Mutation Burden Combined With Immune Infiltrates in the Progression and Prognosis of Advanced Gastric Cancer
por: Guo, Xiong, et al.
Publicado: (2021)

The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

A novel immune classification reveals distinct immune escape mechanism and genomic alterations: implications for immunotherapy in hepatocellular carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Genomic Alteration Characterization in Colorectal Cancer Identifies a Prognostic and Metastasis Biomarker: FAM83A|IDO1
por: Liu, Zaoqu, et al.
Publicado: (2021)

Ryanodine receptor (RYR) mutational status correlates with tumor mutational burden, age and smoking status and stratifies non-small cell lung cancer patient prognosis
por: Wang, Yang, et al.
Publicado: (2022)

TP53 R273C Mutation Is Associated With Poor Prognosis in LGG Patients
por: Zhang, Jian, et al.
Publicado: (2022)

Development and validation of a robust immune-related risk signature for hepatocellular carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Commentary: Stereotactic Body Radiotherapy vs. Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis
por: Li, Zhaonan, et al.
Publicado: (2021)

Association of a Novel Prognosis Model with Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Thyroid Carcinoma
por: Zhang, Siqin, et al.
Publicado: (2021)

A Multi-Gene Model Effectively Predicts the Overall Prognosis of Stomach Adenocarcinomas With Large Genetic Heterogeneity Using Somatic Mutation Features
por: Liu, Xianming, et al.
Publicado: (2020)

Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

Quantitative proteomic analysis of skeletal muscles from wild-type and transgenic mice carrying recessive Ryr1 mutations linked to congenital myopathies
por: Eckhardt, Jan, et al.
Publicado: (2023)

Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2022)

Identification of the Germline Mutation Profile in Esophageal Squamous Cell Carcinoma by Whole Exome Sequencing
por: Deng, Jiaying, et al.
Publicado: (2019)

SLC6A8 is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma
por: Fan, Yongfei, et al.
Publicado: (2022)

Combination of Tumor Mutational Burden and Specific Gene Mutations Stratifies Outcome to Immunotherapy Across Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
por: Peng, Ying-Peng, et al.
Publicado: (2021)

Editorial: Using multi-omics to develop new strategies to improve prognosis and immunotherapy outcomes in cancers
por: Cao, Chenxi, et al.
Publicado: (2023)

Analysis of the Clinicopathologic Characteristics of Lung Adenocarcinoma With CTNNB1 Mutation
por: Zhou, Chao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qmt12t2qfgnbhc8u2p8jk49jmq